Search results
Results from the WOW.Com Content Network
Bromocriptine, originally marketed as Parlodel and subsequently under many brand names, [1] is an ergoline derivative and dopamine agonist that is used in the treatment of pituitary tumors, Parkinson's disease, hyperprolactinaemia, neuroleptic malignant syndrome, and, as an adjunct, type 2 diabetes.
Prolactin inhibitors are mainly used to treat hyperprolactinemia (high prolactin levels). [1] Agonists of the dopamine D 2 receptor such as bromocriptine and cabergoline are able to strongly suppress pituitary prolactin secretion and thereby decrease circulating prolactin levels, and so are most commonly used as prolactin inhibitors. [1]
They are particularly effective in controlling the nausea and vomiting produced by cancer chemotherapy and are considered the gold standard for this purpose. [ 1 ] The 5-HT 3 antagonists may be identified by the suffix -setron , [ 2 ] and are classified under code A04AA of the WHO 's Anatomical Therapeutic Chemical Classification System .
Santarus and VeroScience Announce Publication of AACE Expert Panel Recommendations for CYCLOSET ® (bromocriptine mesylate) for the Management of Type 2 Diabetes Experts conclude that favorable ...
Cabergoline is frequently used as a first-line agent in the management of prolactinomas due to its higher affinity for D 2 receptor sites, less severe side effects, and more convenient dosing schedule than the older bromocriptine, though in pregnancy bromocriptine is often still chosen since there is less data on safety in pregnancy for ...
Average five-year survival rate for lung cancer patients is 25% because only 21% of lung cancers get diagnosed in early stage. How that could change Lung cancer screening guidelines updated, NY ...
According to the cancer society's estimates, there will be 238,340 new cases of lung cancer and 127,070 deaths from the disease this year. Lung cancer is so deadly because most people aren't ...
Current clinical practice guidelines from the AACE rate sulfonylureas (as well as glinides) below all other classes of antidiabetic drugs in terms of suggested use as first, second, or third line agents - this includes Bromocriptine, the bile acid sequestrant Colesevelam, α-glucosidase inhibitors, Thiazolidinediones (glitazones), and DPP-4 ...